Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.81 - $18.96 $1.51 Million - $1.82 Million
95,800 New
95,800 $1.73 Million
Q2 2018

Aug 14, 2018

SELL
$16.77 - $24.71 $83,850 - $123,550
-5,000 Reduced 0.71%
695,000 $16.9 Million
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $5.62 Million - $9.55 Million
500,000 Added 250.0%
700,000 $13.3 Million
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $3.08 Million - $6.43 Million
200,000
200,000 $3.52 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.